PCOS (Polycystic Ovary Syndrome) Caregiver and Family Resources
A guide for caregivers and family members supporting someone with PCOS. Covers diagnosis, treatment options, emotional support strategies, and when to seek specialist care.
19 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 19 of 19 clinical reviews.
A guide for caregivers and family members supporting someone with PCOS. Covers diagnosis, treatment options, emotional support strategies, and when to seek specialist care.
A comprehensive clinical history of PCOS treatment from the 1930s to today, covering surgical, hormonal, metabolic, and emerging therapies, with primary-source citations throughout.
PCOS is a hormonal and metabolic condition that affects an estimated 6-12% of reproductive-age women and is associated with a meaningfully higher rate of depression, anxiety, and disordered eating. This article explains the plausible mechanisms, how clinicians screen, what treatments have evidence behind them, and where the research is still incomplete.
PCOS affects 6 to 12% of reproductive-age women yet takes an average of 2 years and 3 clinicians to diagnose correctly. Learn which conditions mimic PCOS, which PCOS-related conditions get missed, and how the 2023 international guidelines changed the diagnostic framework.
PCOS raises risk for type 2 diabetes, cardiovascular disease, NAFLD, depression, and more. Learn which comorbidities to screen for, when, and how current guidelines direct treatment.
Step-by-step PCOS diagnostic algorithm based on Rotterdam criteria, Endocrine Society guidelines, and AE-PCOS Society recommendations. Covers hyperandrogenism testing, ovulatory assessment, ultrasound criteria, and phenotype classification.
A practical, evidence-conscious guide to current PCOS mechanism research, what is established, and which proposed targets remain experimental.
A guide to the latest PCOS research, including GLP-1 receptor agonists, ovasitol, anti-Müllerian hormone diagnostics, and ongoing clinical trials for polycystic ovary syndrome.
The 2023 International PCOS Guideline recommends 150 minutes of moderate aerobic exercise weekly plus 2 resistance sessions, improving insulin sensitivity.
A decision framework for first-line PCOS management covering lifestyle, metformin, hormonal contraception, and GLP-1 receptor agonists, with citations from Endocrine Society, ADA, and primary trial data.
PCOS has a strong genetic component, with heritability estimates of 70%. Learn how family history shapes risk, which genes are involved, and how diagnosis and treatment strategies adapt when PCOS runs in your family.
A head-to-head comparison of PCOS diagnosis and treatment guidelines from the ADA, AACE, Endocrine Society, and the 2023 International Evidence-Based Guideline, with dosing, drug names, and cited trials.
Evidence-based PCOS monitoring schedule with specific lab tests, imaging timelines, and follow-up intervals recommended by the Endocrine Society, ADA, and AACE guidelines.
Evidence-based nutrition and lifestyle protocols for PCOS (Polycystic Ovary Syndrome), including dietary patterns, exercise recommendations, supplements, and GLP-1 therapies backed by clinical trials and major society guidelines.
A look at the unresolved diagnostic, metabolic, and treatment controversies in polycystic ovary syndrome, framed around what a patient or clinician actually needs to decide.
A comprehensive, evidence-based review of how PCOS diagnosis, symptoms, and treatment outcomes differ across racial and ethnic groups, with clinical guidance for equitable care.
Beyond the classic triad of irregular periods, hyperandrogenism, and polycystic ovaries, PCOS can appear in ways that delay diagnosis for years. Learn the uncommon phenotypes, diagnostic pitfalls, and evidence-based workup strategies.
An evidence-based PCOS treatment algorithm organized by line of therapy, covering lifestyle, metformin, combined oral contraceptives, letrozole, GLP-1 agonists, and surgical options with full citations.
A guide to stopping PCOS treatments safely, including metformin, GLP-1 receptor agonists, oral contraceptives, and spironolactone. Covers withdrawal effects, rebound risks, and how to taper each medication class.